Accelerating Clinical Insights: How to Use Accelerator Mass Spectrometry to Make Better Early Development Decisions

Abstract

This paper is an overview of the applications of the technique of Accelerator Mass Spectrometry (AMS) in the biomedical drug development field. The work described here has been carried out at Xceleron (York, UK and Germantown, MD, USA), and it aims to apply AMS to provide better information about the human pharmacokinetic/metabolic behaviour of drugs or drug candidates as early as possible. It is hoped that the use of this technique will contribute to the delivery of better, more effective drugs onto the market sooner, which will be good news for all concerned.

Keywords

accelerator mass spectrometry AMS drug development

Get full access to this article

View all access options for this article.

References

FDA (2004). Challenge and opportunity on the critical path to new medical products, 38pp. Silver Spring, MD, USA: US Food and Drug Administration. Available at: http://www.fda.gov/downloads/ScienceResearch/SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/ucm113411.pdf (Accessed 07.06.10).

Lappin

& Garner

R.C.

(2008). The utility of microdosing over the past 5 years. Expert Opinion on Drug Metabolism & Toxicology 4, 1499–1506.

European Union Microdose AMS Partnership Programme (2009). The Microdosing Approach Project. Available at: http://www.eumapp.com/ (Accessed 07.06.10).

Center for Drug Evaluation and Research CDER (2008). Guidance for Industry — Safety Testing of Drug Metabolites, 11pp. Silver Spring, MD, USA: US Food and Drug Administration. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm079266.pdf (Accessed 07.06.10).

ICH (2009). ICH Harmonised Tripartite Guideline. Guidance on Non-Clinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals, M3(R2), 25pp. Geneva, Switzerland: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Available at: http://www.ich.org/LOB/media/MEDIA5544.pdf (Accessed 12.11.10).